Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations

NCT ID: NCT02722915

Last Updated: 2020-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

81 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is the examination of brain plasticity on verbal auditory hallucinations (AVH) after neuromodulation with fMRI (functional magnetic resonance imaging) neurofeedback. During the training of fMRI neurofeedback subjects are trained to regulate consciously the connectivity of areas which are associated with hallucinations.The aim is to improve perceived hallucinations' intensity in everyday life of the patients as well as investigating the impact of neurofeedback on resting-state networks in the brain. As control groups, control subjects without AVH and participants with AVH, but no psychiatric diagnosis will be included.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study investigates the brain plasticity after neuromodulation with fMRI neurofeedback on verbal auditory hallucinations (AVH). The new technique of real-time fMRI enables subjects to influence their brain activity in certain areas based on neurofeedback. Current brain activity as measured by fMRI will be reported to the participants in real time via brain computer interface (BCI). Due to the identification of contingency between feedback and mental strategies subjects are able to control their own brain activity consciously. This provides the opportunity to control symptoms such as AVH. Neurofeedback has been tested on subjects with schizophrenia, leading to conscious control of circumscribed brain areas. Recent studies show that, in addition to the modulation of single areas, neurofeedback can also modulate connectivity between different areas. Thus, it is possible to regulate not only single brain regions but also whole networks.

AVH are a key symptom of schizophrenia. They limit social functions significantly and are resistant to the therapy with antipsychotics in 25 % of cases. AVH also occur in 6-15 % of the healthy population, without meeting any diagnostic criteria for schizophrenia or other psychiatric disorders. This study will perform a direct, not-invasive and selective modulation of networks underlying AVH and assess their neural, cognitive and emotional effects. The focus of this study is on the connectivity between auditory cortex and inferior frontal cortex. Various studies demonstrated that the auditory cortex exhibits an abnormal function in schizophrenia patients. It was shown that during AVH, auditory cortex (superior temporal lobe) and inferior frontal cortex synchronize spontaneously. These regions play an essential role in speech perception and processing. An increased synchronisation of these areas could lead to the development of AVH. This study will try to reduce frontotemporal connectivity to uncouple the regions. Increasing connectivity of both areas will serve as control condition and furthermore intensify the perceived control of the own brain activity and of the associated AVH. Thus, patients will learn which factors influence the appearance of their hallucinations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hallucinations, Verbal Auditory

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fMRI Neurofeedback up-regulation

Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)

Group Type EXPERIMENTAL

fMRI

Intervention Type PROCEDURE

collection of functional brain data for 1 hour per day

Neurofeedback

Intervention Type BEHAVIORAL

Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)

PANAS

Intervention Type OTHER

to assess the mood before and after the fMRI and after 1 week during a telephone interview

AVHRS

Intervention Type OTHER

to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview

SF36

Intervention Type OTHER

questionnaire about life quality after 1 week during a telephone interview

fMRI Neurofeedback down-regulation

Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)

Group Type EXPERIMENTAL

fMRI

Intervention Type PROCEDURE

collection of functional brain data for 1 hour per day

Neurofeedback

Intervention Type BEHAVIORAL

Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)

PANAS

Intervention Type OTHER

to assess the mood before and after the fMRI and after 1 week during a telephone interview

AVHRS

Intervention Type OTHER

to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview

SF36

Intervention Type OTHER

questionnaire about life quality after 1 week during a telephone interview

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fMRI

collection of functional brain data for 1 hour per day

Intervention Type PROCEDURE

Neurofeedback

Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 \& 4; controls without AVH: Days 2 \& 3)

Intervention Type BEHAVIORAL

PANAS

to assess the mood before and after the fMRI and after 1 week during a telephone interview

Intervention Type OTHER

AVHRS

to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview

Intervention Type OTHER

SF36

questionnaire about life quality after 1 week during a telephone interview

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

functional magnetic resonance imaging Positive And Negative Affect Scales Auditory Vocal Hallucinations Rating Scale

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Schizophrenia according to ICD-10 (F2x) with verbal hallucinations or only verbal hallucinations (no psychiatric diagnosis) or healthy subjects without verbal hallucinations
* Fluent German language skills

Exclusion Criteria

* addiction
* severe affective disorder
* any contraindication to MRI examination or claustrophobia
* pregnant or lactating women
* traumatic brain lesions
* acute physical or neurological impairments
* acute suicidal tendency
* Lack of informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RWTH Aachen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Klaus Mathiak, Prof MD PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics

Aachen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-139

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neural Bases of Motivation
NCT07251816 RECRUITING NA